These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33281747)

  • 1. The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.
    Agius L; Chachra SS; Ford BE
    Front Endocrinol (Lausanne); 2020; 11():594041. PubMed ID: 33281747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein.
    Agius L
    Proc Nutr Soc; 2016 Feb; 75(1):10-18. PubMed ID: 26264689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
    Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
    J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes.
    Arden C; Tudhope SJ; Petrie JL; Al-Oanzi ZH; Cullen KS; Lange AJ; Towle HC; Agius L
    Biochem J; 2012 Apr; 443(1):111-23. PubMed ID: 22214556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challenge.
    Ford BE; Chachra SS; Alshawi A; Brennan A; Harnor S; Cano C; Baker DJ; Smith DM; Fairclough RJ; Agius L
    Diabetes Obes Metab; 2020 Nov; 22(11):1985-1994. PubMed ID: 32519798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase.
    Shi JH; Lu JY; Chen HY; Wei CC; Xu X; Li H; Bai Q; Xia FZ; Lam SM; Zhang H; Shi YN; Cao D; Chen L; Shui G; Yang X; Lu Y; Chen YX; Zhang WJ
    Diabetes; 2020 Apr; 69(4):591-602. PubMed ID: 31974143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload.
    Agius L
    Biochem Pharmacol; 2013 Feb; 85(3):306-12. PubMed ID: 23022226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
    Iizuka K
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.
    Lee HJ; Cha JY
    BMB Rep; 2018 Sep; 51(9):429-436. PubMed ID: 30158026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
    Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
    Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency.
    Buziau AM; Oosterveer MH; Wouters K; Bos T; Tolan DR; Agius L; Ford BE; Cassiman D; Stehouwer CDA; Schalkwijk CG; Brouwers MCGJ
    Mol Metab; 2024 Sep; 87():101984. PubMed ID: 38972375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
    Iizuka K
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice.
    Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G
    Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation and role of carbohydrate response element-binding protein in metabolic homeostasis and disease.
    Jois T; Sleeman MW
    J Neuroendocrinol; 2017 Oct; 29(10):. PubMed ID: 28370553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
    Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C
    J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and Long-Term Adaptation to Altered Levels of Glucose: Fifty Years of Scientific Adventure.
    Uyeda K
    Annu Rev Biochem; 2021 Jun; 90():31-55. PubMed ID: 34153217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
    Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B
    Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.